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 The lethal effect in vitro occurred in a
dose-dependent manner.
 The SEM revealed morphological
changes on the tegument of the
worms in vitro.
 B. trimera caused reduction worm’s
burden of different stages
schistosomula, juvenile and adults of
S. mansoni in vivo.
 The in vivo treatments signiﬁcantly
reduced the number of hepatic
granulomas.g r a p h i c a l a b s t r a c ta r t i c l e i n f o
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Treatmenta b s t r a c t
Although its efﬁciency against all Schistosoma species, praziquantel (PZQ) shows low efﬁcacy against
schistosomula and juvenile stages. The potential for development of resistance to PZQ has justiﬁed the
search for new alternative chemotherapies. In this scenario, studies to new formulations, more compre-
hensive and without adverse effects, are being conducted. One viable and promising treatment is the
study of medicinal plants as a new approach to the experimental treatment for Schistosomiasis. Amongst
all the variety of the medicinal species studied, we can highlight Baccharis trimera (Less) DC, known as
‘‘Carqueja-amarga’’. This paper not only describes the effect of crude dichloromethane extract (DE) and
aqueous fraction (AF) obtained from B. trimera, in vitro but also is the ﬁrst one that investigates the
in vivo efﬁcacy of B. trimera against schistosomula, juvenile and adult worms of Schistosoma mansoni
BH strain. In the experiment, mice were treated with DE, AF and PZQ (40 and 200 mg/kg) over the period
of larval development (3 and 30 post-infection; pi), and adult worms (60 days post-infection; pi). The
in vitro results show that the DE and AF effects are dose-dependents, being the 130 lg/mL the most effec-
tive one in a shorter period of incubation. The exposure of the in vitro samples over adult parasites were
able to inhibit 100% of the oviposition in females. Likewise caused the mortality of the parasites with
morphological alterations on the tegument, on the suckers, oral and acetabulum, in both males and
females after 6–72 h of exposure. Additionally, the in vivo treatments against juvenile and adult infection
were more effective compared to the control group untreated. Administrations of AF and DE in day 30 pi
(juvenile worms) show female worm total burden reductions of 75% and 68% respectively. At the same
period of infection reductions of respectively 98% and 97% egg/g in the faeces were seen. In relation to083-862
64 R.N. de Oliveira et al. / Experimental Parasitology 139 (2014) 63–72the different egg developmental stages (oogram), the results showed signiﬁcant reductions, due to the
reduction in the number of worms, especially the females. In conclusion, B. trimera exhibits major
schistosomicidal effects in vivo against immature and adult worms of S. mansoni, opening up perspectives
for future researches on substance or compound isolation and the elucidation of its mechanisms of action.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Amongst all the parasitosis, the schistosomiasis ﬁgures as the
second most neglected tropical diseases, being overcomed only
by malaria. The disease registers high rates of morbidity and mor-
tality especially in tropical and subtropical countries, more specif-
ically in underprivileged communities where there is no access to
drinkable water or adequate sanitation structure (Kamel et al.,
2011; Steinmann et al., 2006).
Nowadays, the schistosomiasis control is primordially based on
chemotherapy. In Brazil, the treatment program of schistosomiasis
control is carried out using praziquantel (PZQ) under standard
doses of 50 mg/kg for adults and 60 mg/kg for children. However,
in preventive chemotherapy programs (e.g., in Africa) the dose
used is 40 mg/kg with cure rate of 80–90% (Katz and Coelho,
2008). Although it is efﬁcient against all human schistosomes, pra-
ziquantel shows low efﬁcacy against schistosomula and its juve-
niles stages, allowing lower cure rates in areas with high
endemicity (Abath et al., 2000; Doenhoff et al., 2008). Moreover,
repetitive use of the drug has brought resistance and tolerance
by Schistosoma S. mansoni in different areas and by different strains
of the same area, reafﬁrming an urge to develop new treatment
alternatives (Doenhoff et al., 2008; Fallon et al., 1995; Parise-Filho
and Silveira, 2001; Pica-Mattoccia and Cioli, 2004).
One viable and promising treatment is the study of medicinal
plants as a new approach to the experimental treatment for schis-
tosomiasis (Allegretti et al., 2012; Moraes, 2012; Ndamba et al.,
1994). The research on medicinal plants is encouraged by the
World Health Organization (WHO, 2002), considering that certain
traditional knowledge on curative plants could add up to the devel-
opment of new pharmaceutical products as well as to the combat
against diseases that affects the populations of underdeveloped
countries.
Amongst all the variety of medicinal species studied, we can
highlight Baccharis trimera (Less) DC known as ‘‘Carqueja-amarga’’,
highly used in traditional medicine as a treatment or prevention
against hepatic diseases, rheumatism and morbid obesity (Borella
et al., 2006; Dickel et al., 2007; Fukuda et al., 2006;Torres et al.,
2000; Verdi et al., 2005). Furthermore, other biological effects were
already evidenced by Simões-Pires et al. (2005), who could demon-
strate the antioxidant and anti-inﬂammatory activity of the acqu-
eous extract. Gamberini et al. (1991) have already evidenced the
reduction of the acidity and also the stress-induced and ethanol-
induced gastric wounds in laboratory mice, as well as the relaxa-
tion of the smooth bowel musculature. Oliveira et al. (2005) eval-
uated the antidiabetic activity of the ethanolic crude extract as
well the aqueous and butanolic fractions which were obtained
from the aerial parts of B. trimera. Pádua et al. (2010) have de-
scribed the antioxidant activity of the hydroalcoholic crude extract,
either in vitro or in vivo tests.
Recently, the promising antischistosomal activity of B. trimera
has been evidenced by in vitro tests using essential oils, hydroalco-
holic crude extract and hexanic fraction on S. mansoni adult worms
(Allegretti et al., 2012; de Oliveira et al., 2012; Oliveira et al., 2013).
In the study it was observed that these samples caused signiﬁcant
mortality of schistosome showing morphological changes in the
tegument analyzed by scanning electron microscopy (SEM) in a24-h incubation. The same analysis evidenced the inhibition of
the oviposition by females when the worms were exposed to
sub-lethal concentrations.
Due to the high prevalence, wide distribution of schistosomia-
sis, limitation of drugs for the treatment and control of this helmin-
thiasis, it is necessary to study alternative therapeutics. In this
scenario, it is necessary to conduct studies to new and more com-
prehensive formulations without adverse effects. This paper de-
scribes the effect in vitro and in vivo of crude dichloromethane
extract (DE) and aqueous fraction (AF) obtained from B. trimera
against immature and adult worms of Schistosoma mansoni BH
strain for the ﬁrst time.
2. Materials and methods
2.1. Plant material
Leaves of B. trimera, cultivated at CPQBA 1, a variety developed
by mass breeding at the Chemical, Biological and Agricultural Plu-
ridisciplinary Research Center (CPQBA) of the State University of
Campinas (Unicamp, Campinas, São Paulo, Brazil), were collected
in an experimental ﬁeld. The plant was identiﬁed by Prof. Dr. Grady
L. Webster (University of California, Davis, USA). Its exsiccata is
preserved at the herbarium of CPQBA under the number 1286
(de Oliveira et al., 2012).
2.2. Extraction protocols or preparation of B. trimera extracts
In order to prepare B. trimera dichloromethane extract, the fresh
aerial part residues of the plant were used right after the essential
oil extraction. An amount of 100 g of dried plant was extracted and
so crushed in a (Polytron) dispenser together with 800 mL of
dichloromethane solvent (Sigma–Aldrich) for ﬁve minutes. The
extract was ﬁltered using a funnel with porous plate and was dried
under vacuum using a rota-evaporator. To obtain the aqueous frac-
tion (AF) 4.0 g of dichloromethane extract (ED) was used. Initially,
the ED was solubilized with 120 mL of acetone and 80 mL of dis-
tilled water using an ultrasonic bath. The extraction was proceeded
in a separatory funnel. The fraction containing water and acetone
was dried by the rota-evaporator vacuum until complete the re-
moval of the solvents.
2.3. Testing toxicity of the prepared extracts
A mammalian cell line, vero cells, obtained from Piracicaba
Dental School of the State University of Campinas – UNICAMP,
was used for evaluating toxicity of the extracts. Stock and experi-
mental cultures were grown in a medium containing 5 mL RPMI-
1640 (Gibco Brl, Life Technologies) supplemented with 5% fetal
bovine serum. Experimental cultures were also supplemented with
penicillin: streptomycin (1000 lg/mL: 1000 UI/mL, 1 mL/L).
The cells (100 lL cells/well, inoculation density from 3 to 6  104
cells/mL) in 96-well plates were exposed to different concentra-
tions of dichloromethane extract and aqueous fraction
(0.25–250 lg/mL, 100 lL/well) in DMSO/ RPMI 1640/FBS 5%, at
37 C and 5% of CO2, for 48 h. Final DMSO concentration did not
affect cell viability. Before and 48 h after sample addition, cells
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determined by spectrophotometric quantiﬁcation (540 nm) of cel-
lular protein content using sulforhodamine B assay, by measuring
absorbance at the beginning of the incubation (time zero, T0) and
48 h post-incubation for compound-free (T1) as well as tested (T)
cells. The concentration- response curve for vero cells, TGI (concen-
tration that produces total growth inhibition or cytostatic effect)
was determined through non-linear regression analysis using soft-
ware ORIGIN 8.0 (Denny et al., 2008; Shoemaker, 2006).
2.4. Parasites, intermediate and deﬁnitive hosts
The life cycle of S. mansoni (BH strain from Belo Horizonte, MG,
Brazil) is maintained in Biomphalaria glabrata, which is the inter-
mediate host, at the Department of Animal Biology, IB, UNICAMP.
As deﬁnitive host, Swiss/SPF female mice, weighing 20 g and
4 weeks of age, were previously infected by means of exposure
to a suspension containing 70 cercariae using the tail immersion
technique as described by Oliver and Stirewalt (1952). The exper-
iments were approved by the Ethics Commission for the Use of
Animals (CEUA/UNICAMP, protocol no 2170-1), as they were in
accordance with the ethical principles of animal experimentation
adopted by CEUA.
2.5. Assessment of the anti- Schistosomal effects of the prepared
extracts in vitro
Eight weeks following infection, adult S. mansoni worms were
retrieved by perfusion of the hepatic portal system and mesenteric
veins. These were washed in RPMI-1640 (Nutricell) medium sup-
plemented with 0,05 g/L of streptomycin, 10.000 UI/ml of penicil-
lin, 0,3 g/L of L-glutamine, 2,0 g/L of D-glucose, 2,0 g/L of NaHCO3
and 5,958 g/L of Hepes. After being washed, a couple of warms
was transferred to each well of a 24-well culture plate (TPP) con-
taining the same medium. Sequentially the plates were incubated
in a CO2 greenhouse at 5% and 37 C (Xiao et al., 2007). S. mansoni
worm pairs were subjected to treatment with serial concentrations
(24, 48, 91 and 130 lg/mL of both extracts). The ﬁnal volume in
each well was 2 mL. The positive control group was treated with
a co-ion (5 and 10 lg/mL) of praziquantel, whereas the negative
control group was kept in RPMI-1640 medium with the addition
of 0.01% of Tween-80 with PBS 2% (the highest concentration of
solvent used). The parasites were kept under the same conditions.
All the experiments were performed in ﬁve replicates. Treated
worms were monitored for their motility, mortality rate and ovipo-
sition at intervals of 2, 4, 6, 24, 48 and 72 h using an inverted opti-
cal microscope DM-500 (Leica). Furthermore, alterations in the
tegument were observed (de Oliveira et al., 2012).
2.6. Scanning electron microscopy examination of the tegument of S.
mansoni
To observe changes in the tegument of adult parasites, schisto-
somes were exposed to treatments in vitro with 130 lg/mL of the
DE and aqueous AF of B. trimera monitored for 24 h and analyzed
by scanning electron microscopy (SEM). Brieﬂy, worms were incu-
bated at 37 C in a CO2 atmosphere (5%) for 24 h. After incubation,%worm reduction ¼ Total worms infected untreated control group
Total worms infected untreated cthe parasites were washed with sodium cacodylate buffer (0.1 M),
ﬁxed in 2.5% glutaraldehyde (pH 7.4) (Merck) during 24 h and
then ﬁxed in 1% osmium tetroxide for 1 h. Specimens were dehy-
drated in increasing concentrations of ethanol (50%, 70%, 80%,
90%, 95% and 100%) for 30 min each, dried in a critical point dryer,
mounted on stubs, metalized with gold particles using Sputter
Coater and, ﬁnally, analyzed and photographed using an electron
microscope (Jeol-JSM-820).2.7. Assessment of the antischistosomal effects of the prepared extracts
in vivo
Thirty-day-old Balb/C albino females (18–20 g) were individu-
ally infected with 70 S. mansoni cercariae through tail immersion,
for a period of 2 h, exposed to light and to a temperature of 28 C
approximately (Oliver and Stirewalt, 1952). In the present study,
a total of 150 S. mansoni-infected mice were used. The samples
were weighed on an analytical balance and, after that process,
were solubilized in a 2% autoclaved ‘‘Phosphate Buffered Saline’’
(PBS) with 0.01% Tween-80 Polysorbate (Merck). All groups were
treated with a single oral dose through esophagus pipeline. Then
concentrations (40 and 200 mg/kg) were calculated according to
the in vitro toxicity test results done beforehand in vero cells and
also according to the acute toxicity test as described by Dias
et al. (2009). The body weight of the animal was also taken into
consideration.2.8. Animal groups
The mice for the experiment were allocated into four groups
(I–IV), with 30 animals each, at the time of the experiment. Group
(I) was treated after 03 days (lung stage) infection; the group (II)
was treated after 30 days (juveniles worms), with a single dose
(200 mg/kg); the group (III) was treated after 60 days (adults
worms) infection with 40 and 200 mg/kg of DE and AF and same
doses for PZQ (control pharmacological). Finally, the group (IV)
as negative control infected and untreated. All animals were given
0.3 ml of ‘‘Phosphate Buffered Saline’’ PBS on the respective days of
treatment. The treated groups are shown in Table 2.2.9. Mice perfusion and worm recovery
The group (I) treated after 03 days of infection, was euthanized
after 42 days post treatment. The group (II) treated 30 days post
infection and group (III) treated 60 days post infection were eutha-
nized after two weeks post treatment by cervical dislocation. The
analysis of the group (IV) control, infected but untreated, followed
the same scheme. Parasite worms were retrieved through perfu-
sion of the hepatic portal and the mesenteric veins according to
Pellegrino and Siqueira (1956). The percentage of worm reduction
(WR) was calculated according to Delgado et al. (1992), using the
formulation:Total worms treated group
ontrol group
 100
Table 1
In vitro effects of dichloromethane extract and aqueous fraction against adult worms
of S. mansoni after an incubation period of 72 h.
Samples lg/mL Period of
incubation
(h)
Couples
separated
worms
(%)
Mortality
of the
worms
(%)
Worms with
tegumental alterations
(72 h)
Insigniﬁcant Signiﬁcant
Dichloromethane
extract
0–6 40 60 S
24 80 100 S
130 lg/mL 48 100 100 S
72 100 100 S
0–6 0 0 I
24 80 40 S
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animals
The counting of the eggs eliminated through the faeces was per-
formed on the day of the analysis of the treatments. The faeces
were collected before the euthanasia and were examined in se-
quence, utilizing Kato- Katz quantitative method (Katz et al.,
1972). The percentages of the different developmental stages,
immature, mature and dead egg (oogram) were examined from
the small intestinal wall of infected mice and were computed at
day 45 and 60 after infection in accordance with the method de-
scribed by Hermeto et al. (1994) and Pellegrino et al. (1962).91 lg/mL 48 100 100 S
72 100 100 S
0–6 20 20 I
48 lg/mL 24 60 60 S
48 60 60 S
72 100 100 S
0–6 20 0 I
24 lg/mL 24 40 0 I
48 60 60 S
72 100 80 S
Aqueous fraction 0–6 100 0 I
24 100 100 S
130 lg/mL 48 100 100 S
72 100 100 S
0–6 4 0 I
24 80 40 I
91 lg/mL 48 100 100 S
72 100 100 S
0–6 20 0 I
48 lg/mL 24 60 40 I
48 100 80 S
72 100 100 S
0–6 0 0 I3.1. Histological methods
Regarding the histological analysis, liver samples (left lobe)
were taken from the treated mice and also from the negative con-
trol group (infection untreated). The samples were ﬁxed in 10%
formaldehyde (Sigma–Aldrich), dehydrated in increasing concen-
trations of ethanol, diaphanized in xylol (Sigma–Aldrich), and in-
cluded in parafﬁn (Merck). To a better deﬁnition of the
granulomatous reactions, the histologic sections were colored with
Masson trichrome according to Drury and Wallington (1980). To
evaluate the sections, the choice was the bright ﬁeld microscopy
followed by image capture and processed by using Leica Image
Manager 50. All the granulomas found in 10 histologic section ran-
dom ﬁelds were counted. However, only the diameter was mea-
sured, the largest and the smallest ones, from the granulomas
presenting one single S. mansoni egg.24 lg/mL 24 40 20 I
48 60 60 S
72 100 80 S
Praziquantel
5 lg/mL
0–6 0 80 S
24 0 100 S
48 0 100 S
72 0 100 S
Praziquantel
10 lg/mL
0–6 0 100 S
24 0 100 S
48 20 100 S
72 20 100 S3.2. Statistical analysis
The results were analysed throughout statistical and non-
parametrical tests, using the SAS 9.1 statistics software (SAS
Institute Inc., Carry, NC, EUA). The difference in the mean values
was considered signiﬁcant in a 5% rate.Control 72 20 0 I
Incubation period – 72 h; Control – RPMI-1640; I, Insigniﬁcant; S, Signiﬁcant.4. Results
4.1. Effect of dichloromethane extract and aqueous fraction on the
survival and the motor activity of S. mansoni in vitro
The survival adult of S. mansoni, which was exposed to the
treatment with DE and AF, depended directly on the evaluated con-
centration and the incubation period. The concentrations 130, 91
and 48 lg/mL were lethal to 100% of males and females in the 6–
72 h incubation intervals. However, the individuals exposed to
130 lg/mL of DE showed regurgitation and low contraction over
the body. After 4 h and after 6 h of incubation 60% of male worms
were dead (Table 1). The concentration – 24 lg/mL – also caused a
signiﬁcant mortality (p < 0.01) amongst males and females in 72 h
of incubation. The positive control group was treated with PZQ in
concentrations of 5 and 10 lg/mL (Table 1) what was lethal to
100% of the worms after 2–4 h of incubation. As expected, all the
worms incubated in RPMI-1640 managed to stay alive until the
end of the experiment – 72 h. Concerning the motility, a signiﬁcant
reduction in the parasites movements was observed in all concen-
trations. The percentage of worms that had their motility reduced
was directly proportional to the concentration and to the period of
incubation, as shown in Table 1.4.2. Effect of the dichloromethane extract and the aqueous fraction on
the mating of the worms and the oviposition of S. mansoni in vitro
All the tested extracts inﬂuenced the process of natural mating,
having 100% of the worms been separated, upper to the negative
control group, kept in RPMI-1640 medium until 72 h of incubation.
Moreover, concentrations that were not 100% lethal to the worms
were proven as efﬁcient mating inhibitors, once all of them sepa-
rated the couples in all samples (Table 1). The egg production in
S. mansoni adult females was observed after 2 h of exposure to dif-
ferent concentrations of DE, AF, and PZQ compared to the negative
control group. The treatments evidenced the suppression of the
elimination of eggs in all concentrations, even the sub-lethal one
(24 lg/mL), in 72 h.
4.3. Tegumental changes of S. mansoni adult worms in response to the
treatment with B. trimera visualized by scanning electron microscopy
(SEM)
Tegument alterations were observed on S. mansoni adult males
and females after 24 h incubation in vitro under the concentration
Fig. 1. Scanning electron microscopy of adults S. mansoniworms after their exposition to the dichloromethane extract of B. trimera in the concentration of 130 lg/mL during a
24 h incubation period in vitro (A, C, and E) –Male worms – contraction, peeling of spines and tubercles, blebs between tubercles and changes in oral sucker (OS) and oral
ventral (VS) – (B, D, and F) – Female worm – contraction, peeling and swelling of dorsal region, changes in oral sucker (OS) and oral ventral (VS) – (cg) gynaecophoric canal.
Fig. 2. Scanning electron microscopy of adults S. mansoni worms after their exposition to the aqueous fraction of B. trimera in the concentration of 130 lg/mL during a 24 h
incubation period in vitro (A, C, and E) – Male worms – tegument peeling, destruction of tubercles and spines and changes in oral sucker (OS) and ventral (VS). (B, D, and F) –
Female worm– corrugation of tegument area and changes in oral sucker (OS) and ventral (VS).
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sented morphologic alterations (Fig. 1A and B). In male worms
the treatment induced tubercles and spine tegumental damage
on its dorsal surface, the accession of bubbles surrounding the
morphologically altered tubercles, besides the sucker destruction(Fig. 1C and E). The female parasites presented a swollen dorsum
(only visible through SEM), tegument scaling, oral sucker altera-
tions and acetabulum alteration (Fig. 1D and F). Concerning the
treatment with AF, the male worms presented tuber destruction,
spines and sucker alterations (Fig. 2A, C and E). However, female
Fig. 3. Scanning electron microscopy of adults S. mansoni. (A, B, C) – Male worms; (D–F) – Female worm of Control group kept only in RPMI-1640 medium during a 24-h
incubation period in vitro. (S) spines – (cg) gynaecophoric canal.
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er alterations (Fig. 2B, D and F). The control group parasites, RPMI-
1640 incubated, did not show any morphological changes (Fig. 3).
4.4. Effect of the prepared extracts on vero cells
It indicates the absence of cytotoxic effects of the studied ex-
tracts. Thus, the concentrations in which DE and AF presented
the schistosomicidal activity in vitrowere not associated with cyto-
toxic effects on vero cells.5. Treatment efﬁcacy in vivo
The in vivo treatments performed via oral in a single dose of
200 mg/kg of DE and AF of B. trimera signiﬁcantly reduced the
worm burden of the treated mice altering the male and female
worm ratio, showing that females were more sensitive. The treat-
ments against juvenile and adult infection were more effective
compared to the untreated control group. Concerning the number
of eggs excreted in the faeces and different egg developmental
stages (oogram), the results showed signiﬁcant reductions, empha-
sizing the relationship, due to the reduction in the number of
worms, especially the females. The distribution of adult parasites
retrieved from the mesenteric veins and the portal system of mice
treated with B. trimera as well as the control groups – treated with
PZQ – and the untreated infected group is summarized on Table 2.
5.1. Response of the immature worms of S. mansoni to a single dose of
Baccharis trimera
The mice treated with a single dose (200 mg/kg) of B. trimera,
after 03 and 30 days of infection showed signiﬁcant differences
(p < 0.01 and p < 0.001) regarding the reduction of male, female
and total worm burden, especially for the reduction of the excreted
eggs in the faeces. The treatments performed againstschistosomula showed a moderate reduction of the total worm
burden of 47.4%; 42% and 12.2% when the mice received AF, DE
and (40 mg/kg) of PZQ respectively, compared to the untreated in-
fected control group. In contrast, the treatments showed a reduc-
tion of the eggs eliminated in the faeces (98%, 97.6% and 69.3% in
animals treated with AF, DE and PZQ, respectively).
Regarding the treatments against juvenile worms, a better
activity of B. trimera was observed in the same parameters as de-
scribed above. The animals treated with AF, DE and PZQ showed
a total reduction of the worm burden of 75%; 68% and 37%, respec-
tively. Promising results were also presented regarding the reduc-
tion of eggs excreted in the faeces (98%, 97% and 57% with AF, DE
and PZQ treatments, respectively). Comparing the two treatment
periods (03 and 30 days PI) in oogram, it was observed that only
the variant of the mature eggs, was signiﬁcantly (p < 0.01) different
among the tested samples. In Table 2, all results are summarized.5.2. Response of the adult S. mansoni to B. trimera
After 60 days of infection, the treatments performed with DE
and AF on doses of 40 and 200 mg/kg signiﬁcantly reduced
(p < 0.05 and p < 0.001) the worm burden of the mice to 52.7%
and 66%, 47% and 62% respectively. However the treatments with
40 and 200 mg/kg of PZQ showed a low worm burden of 45% and
49.4% on the adult compared to treatments of B. trimera and the
untreated infected control group. In relation to the number of eggs
excreted in the faeces, the results showed reductions of 62% and
91%; 41% and 76% in response to treatments with 40 and
200 mg/kg of DE and AF, respectively. Nevertheless, the PZQ group
showed a reduction of 50% and 63.4% for doses of 40 and 200 mg/
kg. Meanwhile, the treatments with DE and AF caused a signiﬁcant
reduction (p < 0.001) of immature, mature, and dead eggs retained
in the intestinal tissue, when compared to the PZQ group (p < 0.01)
and with the untreated infected control group, as shown in Table 2.
Table 2
Effects of B. trimera efﬁcacy against Schistosomula (03 days PI), juvenile (30 days PI) and adult (60 days PI) S. mansoni BH strain.
Infection Samples Single
dose
(mg/
kg)
Mean worm burden ± SE (liver and porto-
mesenteric)
Total
worm
burden%
reduction
Number of
eggs/g faeces
% reduction
% Egg developmental stage ± SE
Male Female Couples Total Immature Mature Dead
SchistosomulaInfection Dichloromethane
extract
200 4 ± 0.91 1.6 ± 0.21 5.4 ± 0.80 15.7 ± 2.2 42⁄ 97.6⁄⁄ 53.1 ± 8.7 23 ± 4.8 6.2 ± 2.3
Aqueous fraction 200 2.3 ± 0.49 0.7 ± 0.21 5.7 ± 0.61 14.2 ± 1.4 47.4 ⁄⁄ 98⁄⁄ 61.6 ± 5.7 19.2 ± 2.7 9 ± 1.1
Praziquantel 40 4.3 ± 0.86 2.8 ± 0.71 8.3 ± 0.78 23.7 ± 2.5 12.2 69.3⁄ 79.4 ± 4.7 12.4 ± 1.9 5.3 ± 1.3
Control infected
untreated
PBS 6.7 ± 1.1 2.6 ± 0.61 8.8 ± 0.89 27 ± 2.4 – – 85.5 ± 18.8 7.2 ± 1.2 1.2 ± 0.7
Juvenile infection Dichloromethane
extract
200 5.4 ± 1.60 1.0 ± 0.27 4.9 ± 1.12 14.9 ± 2.07 68⁄ 97⁄⁄ 42.7 ± 8.9 66.6 ± 15.4⁄ 4.4 ± 1.3
Aqueous fraction 200 3.9 ± 0.86 0.2 ± 0.2 3.9 ± 0.56 11.9 ± 1.40 75⁄⁄ 98⁄⁄ 36.7 ± 8.05 62.7 ± 13.5⁄ 5.0 ± 1.8
Praziquantel 40 5.9 ± 1.17 2.5 ± 0.84 10.6 ± 1.11 29.6 ± 2.10 37 57⁄ 69.4 ± 8.5 14.8 ± 7.3 1.2 ± 1.2
Control infected
untreated
PBS 12.9 ± 1.1 9.9 ± 1.20 13.1 ± 1.06 47.6 ± 3.27 – – 119 ± 7.02 29.2 ± 4.7 2.7 ± 0.7
Dichloromethane
extract
40 5.6 ± 0.6 3.6 ± 0.7 5.6 ± 0.7 20.1 ± 1.6 52.7⁄⁄ 62⁄⁄ 33 ± 9.7 117 ± 15 15 ± 2.7
Aqueous fraction 40 4 ± 0.7 1.8 ± 0.1 8.3 ± 1 22.5 ± 1.8 47⁄ 41⁄ 23 ± 8.7 84.6 ± 23.4 12.6 ± 3
Adult infection Dichloromethane
extract
200 4.5 ± 1.00 2.2 ± 0.59⁄ 6.0 ± 0.74 11.5 ± 1.52⁄⁄ 66⁄⁄ 91⁄⁄ 8.6 ± 1.92 98.4 ± 12.89⁄⁄ 28 ± 4.58⁄⁄
Aqueous fraction 200 4.4 ± 0.85 1.8 ± 0.44⁄⁄ 7.1 ± 0.65 12.9 ± 0.73⁄⁄ 62⁄⁄ 76⁄⁄ 7.6 ± 2.31 123 ± 3.73⁄⁄ 27.2 ± 2.12⁄⁄
Praziquantel 40 3.6 ± 0.90 2.3 ± 0.80⁄ 8.5 ± 0.77 23.3 ± 2.08 45 50⁄ 81.1 ± 15.06 25.3 ± 2.15 7.5 ± 2.58
Praziquantel 200 5.2 ± 1.8 2.9 ± 0.7 7.6 ± 1.6 21.5 ± 3.2 49.4⁄ 63.4⁄ 82.9 ± 11.5 52.8 ± 7.4 16.7 ± 4.2
Control infected
untreated
PBS 9.6 ± 1.32 8.9 ± 1.27 13 ± 1.91 42.5 ± 3.36 – – 133 ± 8.10 10.5 ± 17.78 3.6 ± 0.70
Values are presented as mean ± SEM. Number of animals/group = 10.
The difference was signiﬁcant ⁄P < 0.01 and ⁄⁄P < 0.001.
Table 3
Granuloma diameter (lm) in the liver of the treated and non – treated groups 60 day
PI.
Sample and doses Granuloma diameter
average (lm) ± SE
Number of
granulomas
Dichloromethane extract
40 mg/kg
263 ± 21.4 61⁄
Dichloromethane extract
200 mg/kg
216 ± 8.58⁄⁄ 45⁄⁄
Aqueous fraction 40 mg/
kg
261 ± 19.4⁄ 50⁄⁄
Aqueous fraction 200 mg/
kg
253 ± 7.89⁄⁄ 51⁄⁄
Praziquantel 40 mg/kg 261 ± 6.29 60⁄
Praziquantel 200 mg/kg 267.5 ± 19 66
Control infected untreated 291 ± 5.9 129
The difference was signiﬁcant ⁄P < 0.01 and ⁄⁄P < 0.001.
R.N. de Oliveira et al. / Experimental Parasitology 139 (2014) 63–72 695.3. Histopathological studies
Decreases in granuloma sizes with minimal degenerative
changes in the liver tissue were observed in the liver of different
treated groups. Considering the histologic analysis of the liver sam-
ples, extracted from the animals treated with DE and AF (40 and
200 mg/kg) there was a signiﬁcant reduction (p < 0.001) in relation
to the number of periovular granulomas formed around the degen-
erate egg. At the same time, there was a reduction in the size of the
granulomatous inﬂammation, indicating the anti-inﬂammatory ef-
fect of B. trimera. Thus, the hepatic granuloma average diameter
was signiﬁcantly smaller (p < 0.01) in the groups treated with DE
and AF, in comparison to the group treated with (40 and 200 mg/
kg) of PZQ (Table 3). The histologic observations on the livers from
the untreated infected control group, evidenced a chronic granu-
lomatous infection characterized by the presence of granulomas
altogether with damaged eggs, as well as a large inﬂammatory
inﬁltration (lymphocytes, macrophages, eosinophils) and ﬁbrous
tissue. Fig. 4 shows the effect of the treatment with DE, AF, and
PZQ on groups of untreated infected animals.6. Discussion
In recent years, a substantial interest in natural products to the
treatment of Neglected Tropical Diseases (NTD’), including schisto-
somiasis, has been growing. The interest has been exploited and
stimulated as an effort to develop a new medicine as an alternative
method to this parasitosis treatment (Moraes et al., 2012; Yousif
et al., 2007). This study is the ﬁrst one investigating the in vivo efﬁ-
cacy of B. trimera (Less) DC against schistosomula, juvenile and
adult worms of S. mansoni BH strain. Nevertheless, as a ﬁrst step,
in vitro antischistosomal studies were performed on adult worms.
The in vitro assay demonstrates that the DE and AF effects are
dose-dependents, being the 130 lg/mL the most effective one in
a shorter period of incubation. Furthermore, it was possible to ob-
serve that the schistosomes exposed to DE and to AF showed slow
contractions, motility reduction and paralysis causing, most of the
time, the parasites death. According to Noel (2008) that paralysis is
associated to important neurotransmitters or neuromodulators
such as dopamine, acetylcholine, serotonine, amongst others. In
relation to PZQ assays (5 and 10 g/mL), all the worms, males and
females, were contracted with no movement whatsoever. Earlier
studies by Pica-Mattoccia and Cioli (2004) inform about the PZQ
effects on the worms, causing contractions whenever the parasite
is exposed to concentrations 0.1 and 1 lg/mL. However, it is
known that PZQ causes a quick calcium inﬂux followed by contrac-
tion, paralysis and tegument destruction. Nevertheless, that pro-
cess was not completely clariﬁed (Doenhoff et al., 2008).
Whereas that the inverted optical microscopy does not allow to
detail the tegumental changes presented in the parasite, a qualita-
tive analysis to evaluate the tegumental damage of specimens after
culture in vitro, through the scanning electron microscopy (SEM)
was used in this study. According to Senft and Gibler (1977), the
SEM allows to observe details of the morphology of the tegument
of S. mansoni making it possible to interpret its functionality. This
technique has been employed by several authors (e.g., El Ridi et al.,
2012; de Oliveira et al., 2012; Neves et al., 2011; Oliveira et al.,
2013) in order to elucidate the mechanisms of action of drugs/
compounds used in the experimental treatment of schistosomiasis.
Fig. 4. Photomicrograph of hepatic granulomas of mice liver 60 days post infesta-
tion (chronic stage), treated with B. trimera and PZQ. (A, B) – Treated group with DE
40 and 200 mg/kg, respectively (C, D) – Treated group with AF 40 and 200 mg/kg,
respectively showing reduction in granuloma size, inﬂammatory cells and less
condensed connective tissue. (E, F) – Treated group with PZQ 40 and 200 mg/kg,
respectively. (G,H) – Control infected untreated. Arrows indicate the eggs of S.
mansoniwith presence of miracidium inside and the presence of inﬂammatory cells.
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AF are related to damage in suckers, oral and acetabular in both
male and female schistosomes. Additionally, qualitative analysis
showed that samples caused a extensive peeling of the in tegument
especially in the dorsal region, resulting in the exposure of the
antigens of this surface. Furthermore, blebs were visible on the teg-
ument of male worms exposed to treatment with DE. Similar re-
sults were observed by Oliveira et al. (2013) who evaluated the
in vitro effect of the hexane extract of B. trimera on S. mansoni. It
is believed that the morphological changes caused by a drug/com-
pound with schistosomicidal activity over sarcoplasmic membrane
and the tegument of the parasite, may be accompanied by an
increasing of the exposure to antigens on the surface of the worm.
Those changes are identiﬁed and connected with the host immune
response, required to complement the activity of the drug (Brind-
ley et al., 1989; Doenhoff et al., 1987). For this reason, this struc-
ture has been investigated in the development of new
antischistosomal drugs since the late 40s to the present days.
The in vivo treatments against immature and adult worms of S.
mansonimodify the proportion between male and female parasites
and cause the reduction of the density of the eggs eliminated in the
faeces and the ones found in the treated animals intestinal tissue,
as well as the number of hepatic granulomas. In this study, we alsoevaluated the effect in vivo of praziquantel on schistosomula, juve-
niles and adults worms. However, the treatments with the usual
dose (40 mg/kg) presented a low worm burden reduction corrobo-
rating with the study of Utzinger et al. (2003) which shows that the
schistosomulas are not susceptible to PZQ. Additionally, it was pos-
sible to observe that DE and AF in vivo treatments against schisto-
somula and juveniles worms with a single dose of 200 mg/kg
present superior results when compared to the pharmacological
control group, treated with PZQ. Thus, considering PZQ as a pure
synthetic drug, we can infer that the DE and AF richness of the
compouds brings a synergic effect potencializing its schistosomi-
cidal action.
Comparable results were obtained by previous trials in vitro and
in vivo conducted by the other authors; using compounds isolated
from species (e.g., Piplartina), isolated from Piper tuberculatum,
Artemether and 8-Hydroxyquinoline derivatives from Artemisia
annua and have demonstrated activity against schistosomula and
juvenile worms of S. mansoni. However, the mechanisms of action
are not elucidated (Allam et al., 2013; El-Lakkany et al., 2013, Mor-
aes et al. 2012a).
Treatments in vivowith B. trimera showed greater sensitivity on
the female worms. It is known that schistosomes, males and fe-
males, respond differently to therapy concerning the drug activity.
However, the present study corroborates with Mostafa et al. (2011)
who observed an increased sensitivity of the female worms S. man-
soni after the treatment with 500 mg/kg of the aqueous extract of
ginger (Zingiber ofﬁcinale). Nour et al. (2006) evaluated the efﬁcacy
of methanol extract of Randia Nilotic, in vivo, and observed that the
female worms are more susceptible to treatment. Lescano et al.
(2004) observed the effect of artemether and reported that females
were more sensitive to treatment than male worms. In studies
with PZQ, Delgado et al. (1992) observed in their experiments that
the in vivo concentration of 250 mg/kg, administered 6 weeks after
infection, acts preferentially on females of this parasite. In contrast,
Drescher et al. (1993), Gonnert and Andrews (1977), Pellegrino
et al. (1977) and Mehlhorn et al. (1981) describe that the subcura-
tive doses of PZQ act in the same proportion on males and females,
with no signiﬁcant differences in the therapeutic sensitivity to
either genders.
According to Harder (2002), the death of adult schistosomes,
owing to the conducting treatment with drugs/compounds with
anti-S. mansoni action, is assigned to metabolic disorders as well
as mechanical and muscle destruction of worms after exposure
to drugs. Furthermore, it is noteworthy that the susceptibility of
this parasite is associated with biological factors such as age, sex,
host and evaluated strain. Such factors may interfere with suscep-
tibility of infection, fecundity and consequently the production of
eggs (Incani et al., 2001; Liang et al., 2010).
Considering the above, the in vitro treatments suppressed the
oviposition of all the concentrations evaluated and the in vivo
treatments presented a reduction in the number of eggs eliminated
in the faeces after treatments against juvenile and adult worms to
both DE and AF treatments besides the demonstration of a signiﬁ-
cant difference in the percentage of mature eggs kept on the intes-
tinal tissue of the treated animals (Table 2) when compared to the
percentages of the control groups, treated with PZQ and infected
untreated. Pellegrino et al. (1962) reported that mice infected with
S. mansoni have started eliminating eggs around the 30th day of
infection. However treatments performed before and after infec-
tion are important at this period. Our results are conﬁrmed by Pra-
ta (1957) in a classic theory which says that if the oviposition
ceases are reduced within the evaluated drug administration, the
oogrammust showmore mature eggs than immature ones, as a re-
sult of anterior oviposition.
The results presented, concerning the reduction of eggs, should
be considered extremely signiﬁcant once the egg is responsible for
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cycle interfering, thus, in the epidemiology of schistosomiasis in
endemic areas. Furthermore, according to Gryseels et al. (2006)
the pathology of the schistosomiasis is not directly associated to
the presence of the adult worm, but to the large number of eggs
that are stuck in the host’s tissues and organs, especially the liver,
triggering an inﬂammatory process called granulomas.
Finally, the study of the activity of a drug/compound on the
granulomatous reaction that forms around the eggs of S. mansoni
is very important once it is responsible for the major pathogenesis
of a severe chronic phase of schistosomiasis characterized by ﬁbro-
sis, especially in the liver tissue (Lichtenberg, 1964). According to
Friedman (2008), the process of ﬁbrosis in the granulation tissue
of the liver, induced by the release of egg antigens of S. mansoni,
depends on the activation of a particular cell type called stellate
parasinusoidale cell, known as the major source of ﬁbrillar
collagens.
The histopathological analysis of the livers of animals treated
with ED and AF after 60 days of infection showed a reduction of
the number of granulomas and signiﬁcant differences between
the average diameters, compared to the groups treated with prazi-
quantel and the negative infected and untreated control group.
Classic investigations such as done by Doenhoff et al. (1986) report
that there is a signiﬁcant correlation between the numerical de-
crease in the diameter of the hepatic granulomas and the number
of eggs eliminated in the faeces, both mediated by speciﬁc cells of
the host. This study showed a percentage reduction of 91% and 76%
of eggs eliminated in the faeces for the samples DE and AF, respec-
tively, conﬁrming the observations made by Doenhoff et al. (1986).
Badawy et al. (1991) report that the reduction in diameter of hepa-
tic granuloma may be related to the reduction of pro collagen type
III, responsible for the formation of granulomas.
We believe that the reduction of granulomas and granuloma-
tous infection of the animals treated with ED and AF, is due to
the fact that B. trimera presents pharmacological actions such as
anti-inﬂammatory and hepatoprotective activities (Soicke and
Leng-peschlow, 1987; Gené et al., 1996). Another factor that could
promote the reduction of granulomas would be the inhibition of
soluble antigens of the parasite eggs (SEA), resulting in the inacti-
vation or the immune response reduction of the host, mediated by
T cells (TDH), Th1 and Th2 lymphocytes, what mediates the devel-
opment of the granulomatous inﬂammatory response (Wynn and
Cheever, 1995).7. Conclusion
According to the results, the crude dichloromethane extract and
its respective aqueous fraction, extracted from B. trimera, caused
signiﬁcant schistosome mortality through tegument, morphologi-
cal alterations, and, also, oviposition reduction when females were
exposed to in vitro assays. However, the treatments in vivo with a
single dose against different stages of the schistosomula, juveniles
and adults of S. mansoni, caused a reduction in the parasite burden
in the treated animals, as well as the reduction of the viable eggs
elimination, decreasing the number of hepatic granulomas. There-
fore, this study opens up perspectives for future researches on the
substance or the compound isolation, making possible the elucida-
tion of the mechanism of action of B. trimerawhat could be used as
a potential new treatment alternative against S. mansoni.Acknowledgments
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